Top 10: Logistics Providers in Healthcare

The global pharmaceutical and healthcare logistics market is growing in complexity, driven by the growth of biologics, temperature-sensitive medicines, advanced therapies and increasingly international supply chains. 

In response, logistics providers are investing in specialist infrastructure, cold-chain capabilities and digital technologies to ensure medicines and medical products reach patients safely, efficiently and in compliance with stringent regulatory requirements. 

From global freight operators to specialist life-sciences providers, the sector's largest companies are playing an increasingly important role in pharmaceutical distribution, clinical trial supplies and healthcare delivery. 

Healthcare Digital explores 10 of the world's largest logistics groups with dedicated healthcare and pharmaceutical operations, ordered by total group revenue in 2025.

10. GXO Logistics – Healthcare & Life Sciences

HQ: Greenwich, Connecticut

Group CEO: Patrick Kelleher

Annual revenue: US$13.18bn

GXO Logistics is expanding its presence in healthcare and pharmaceutical supply chains, providing specialist warehousing, inventory management and distribution for medicines, medical devices and hospital supplies. 

Its capabilities include temperature-controlled storage and transportation, pharmaceutical co-packing, quarantine management and time-critical deliveries. 

A landmark 10-year NHS Supply Chain agreement, which was expanded in March 2026, alongside partnerships with Siemens Healthineers and bioMérieux, is strengthening its position in the sector. 

Its technology-led approach provides greater inventory visibility, regulatory compliance and supply-chain resilience.

9. Nippon Express – NX Pharma

HQ: Tokyo, Japan

Group CEO: Satoshi Horikiri

Annual revenue: US$16.21bn

Japan-based Nippon Express, part of NX Group, provides specialist pharmaceutical and healthcare logistics through its NX Pharma division. 

Its services span GDP-compliant transportation, temperature-controlled warehousing, pharmaceutical distribution and clinical-trial supply chains. 

The group also supports advanced therapies, with dedicated pharmaceutical facilities and an international airfreight network. 

In 2026, it showcased its pharmaceutical capabilities at Interphex Osaka, highlighting its specialist infrastructure and growing focus on complex life-sciences supply chains.

8. C.H. Robinson – Healthcare Logistics

HQ: Eden Prairie, Minnesota

Group CEO: David Bozeman

Annual revenue: US$16.23bn

C.H. Robinson is strengthening its position in pharmaceutical and healthcare logistics, surpassing US$1bn in healthcare revenue over the 12 months to March 2026. 

The Minnesotan firm's offering spans temperature-controlled transportation, pharmaceutical distribution, medical-device logistics and clinical-trial supply chains. 

The company operates a network of more than 21,000 temperature-controlled contract carriers, supported by ISO 9001 and EU GDP-certified quality systems. 

Its technology platform, Navisphere, provides shipment visibility, validated temperature monitoring and risk management across complex global healthcare supply chains.

7. Kuehne + Nagel – PharmaChain and HealthChain

HQ: Schindellegi, Switzerland

Group CEO: Stefan Paul

Annual revenue: US$33.95bn

Swiss logistics group Kuehne+Nagel operates a substantial healthcare and pharmaceutical logistics business through its PharmaChain and HealthChain offerings. 

Its services span temperature-controlled air, sea and road freight, specialist warehousing, vaccine distribution, clinical-trial logistics and support for cell and gene therapies. 

In 2026, the company expanded its specialist infrastructure with new temperature-controlled facilities in Hyderabad and Frankfurt, strengthening connections to major pharmaceutical manufacturing and distribution hubs. Its global network includes more than 270 HealthChain-certified locations.

6. DSV – DSV Healthcare

HQ: Copenhagen, Denmark

Group CEO: Jens Lund

Annual revenue: US$37.4bn

Danish logistics group DSV has significantly expanded its healthcare and pharmaceutical capabilities following its 2025 acquisition of DB Schenker, creating one of the world's largest transport and logistics networks. 

DSV's healthcare offering spans temperature-controlled air, sea and road freight, pharmaceutical warehousing, clinical-trial distribution and specialist supply-chain management. 

The group supports pharmaceutical manufacturers, healthcare providers and medical-technology companies, with expertise in GDP-compliant handling and time-sensitive deliveries. Its expanded global footprint strengthens its ability to manage complex life-sciences supply chains.

5. A.P. Moller Maersk – Maersk Healthcare

HQ: Copenhagen, Denmark

Group CEO: Vincent Clerc

Annual revenue: US$54bn

Danish shipping and logistics group A.P. Moller–Maersk has developed an integrated pharmaceutical and healthcare logistics offering spanning ocean and air freight, temperature-controlled warehousing, customs clearance and end-to-end cold-chain management. 

Its services support pharmaceutical manufacturers, biopharmaceutical companies, vaccine producers and medical-technology businesses, with GDP-compliant handling, real-time shipment tracking and temperature monitoring. 

In May 2026, Maersk launched a dedicated weekly refrigerated rail corridor connecting Hyderabad's pharmaceutical manufacturing hub with Nhava Sheva Port, strengthening India's pharmaceutical export supply chains.

4. CMA CGM – CEVA Logistics Healthcare

HQ: Marseille, France

Group CEO: Rodolphe Saadé 

Annual revenue: US$54.4bn

French shipping and logistics group CMA CGM supports pharmaceutical and healthcare supply chains through its subsidiary CEVA Logistics and dedicated Pharma Reefer division. 

CMA CGM and CEVA's services cover GDP-aligned ocean freight, temperature-controlled air cargo, specialist warehousing and end-to-end pharmaceutical distribution. 

CEVA's FORPATIENTS “last mile” offering also supports clinical-trial logistics, biopharmaceuticals and medical technology, serving more than 500 healthcare and life-sciences companies. 

In November 2026, CEVA opened a 17,000 sq m pharmaceutical logistics hub near Strasbourg, featuring temperature-controlled storage down to -25°C and ultra-low-temperature capabilities to -80°C.

3. FedEx – FedEx Life Sciences

HQ: Memphis, Tennessee

Group CEO: Raj Subramaniam 

Annual revenue: US$87.93bn

US-based logistics giant FedEx is strengthening its position in pharmaceutical and healthcare logistics through its dedicated FedEx Life Sciences organisation, launched in July 2026.

Led by Nick Gennari, the division supports pharmaceutical manufacturers, biotech companies and healthcare providers with temperature-controlled transportation, clinical-trial distribution, medical-device logistics and specialist cold-chain services. 

Its global network includes six Life Sciences Centres and 30 IATA CEIV Pharma-certified facilities. Healthcare has become a significant growth area, generating approximately US$10bn in revenue during FY2026.

2. UPS – UPS Healthcare

HQ: Atlanta, Georgia

Group CEO: Carol Tomé 

Annual revenue: US$88.7bn

US logistics heavyweight UPS has established itself as a major player in pharmaceutical and healthcare supply chains through its dedicated UPS Healthcare division. 

Its services span temperature-controlled pharmaceutical distribution, biopharmaceutical logistics, medical-device fulfilment, laboratory diagnostics and clinical-trial support. 

Following acquisitions including German cold-chain specialists Frigo-Trans and Canadian healthcare logistics provider Andlauer Healthcare Group, UPS has expanded its specialist infrastructure and international reach. 

In June 2026, it announced a US$48m investment in 27 temperature-controlled freight cross-dock facilities worldwide, strengthening its ability to handle biologics, advanced therapies and other temperature-sensitive medicines. 

UPS’ global healthcare portfolio generated more than US$11bn in revenue during 2025.

1. DHL Group – DHL Life Sciences & Healthcare

HQ: Bonn, Germany

Group CEO: Tobias Meyer

Annual revenue: US$92.3bn

German logistics giant DHL Group is one of the world's leading providers of pharmaceutical and healthcare supply-chain services, operating across more than 220 countries and territories. 

The DHL Life Sciences and Healthcare Logistics business supports pharmaceutical manufacturers, biopharma companies, medical-device producers and clinical-trial organisations through temperature-controlled transportation, specialist warehousing and end-to-end distribution. 

The group has more than 11,000 certified healthcare specialists, 30 clinical-trial depots and over 250 GDP/GxP-certified sites. 

In April 2025, DHL announced a €2bn (US$2.27bn) investment in healthcare logistics by 2030, targeting pharmaceuticals, biologics, clinical trials and advanced therapies. 

In September 2026, it further strengthened its Singapore infrastructure with new pharmaceutical and cold-chain facilities.